Table 3.
Citation (country) | Methodology | Risk category | Age range (years [median]) | N * | Time period | Incidence (per 100,000 patient-years) |
---|---|---|---|---|---|---|
Meningitis | ||||||
Biernath 2006 (USA) 30 | Cohort study | Cochlear implants | < 6 [55 months] | 4265 | 97–04 | 120 |
Wilson-Clark 2006 (Canada) 31b | Postal survey | Cochlear implants | <18 [–] | 482 | 95–02 | 290 |
<6 [–] | ||||||
< 18 [–] | – | 95–98 | 220 | |||
99–02 | 400 | |||||
< 6 [–] | – | 95–98 | 150 | |||
99–02 | 310 | |||||
Melegaro 2006 (UK) 29 | National hospital database study † | General high-risk patients | < 1 month [–] | – | 95–00 | 15.6 |
1–11 months [–] | 15.3 | |||||
1–4 [–] | 1.7 | |||||
5–9 [–] | 0.2 | |||||
10–14 [–] | 0.2 | |||||
Bacteraemia | ||||||
Steenhoff 2008 (PA, USA) 24 | Retrospective cohort study | HIV infection | – | – | 08–09 | 398 |
Total number of patients in analysis.
Includes some bacterial meningitis cases related to Neisseria meningitidis or of unknown bacterial type.
HIV, human immunodeficiency virus.